Cortagen
Cognitive / NeuroprotectionAlso known as: Brain Cortex Peptide, Cortagen Peptide, Ala-Glu-Asp-Pro
Mechanism
A short peptide from the Khavinson bioregulator family, designed to support the brain's cerebral cortex. It is used in Russian medicine to help with age-related cognitive decline, recovery after strokes, and general brain health. Like other Khavinson peptides, it works by regulating gene expression in the specific tissue it targets — in this case, cortical neurons.
Technical detail
Tetrapeptide (Ala-Glu-Asp-Pro) from the Khavinson bioregulatory peptide class. Proposed mechanism involves epigenetic regulation of gene expression in cerebral cortex neurons, specifically modulating chromatin condensation and DNA methylation patterns to restore age-related transcriptional changes. Normalizes neurotransmitter balance including serotonin, dopamine, and norepinephrine levels in cortical tissue. Demonstrated neuroprotective effects in aging models, reducing lipofuscin accumulation and oxidative damage markers in neuronal cultures. Oral bioavailability confirmed for short peptide bioregulators of this class.
Effects
NERVOUS SYSTEM (NEUROPROTECTION/COGNITION): Cortagen (Ala-Glu-Asp-Pro, AEDP) is a Khavinson bioregulatory peptide designed for brain tissue — part of the peptide bioregulator paradigm developed at the St. Petersburg Institute of Bioregulation and Gerontology [Russian clinical studies]. Proposed mechanism: gene expression modulation via direct DNA interaction — Khavinson's theory holds that short peptides (2-4 amino acids) penetrate the nucleus and regulate gene expression by binding to specific DNA sequences in promoter regions, activating tissue-specific repair and regeneration programs [in vitro — Khavinson lab, theoretical framework]. Neuroprotective effects: reduces neuronal apoptosis in ischemia models, promotes neurite outgrowth, and supports remyelination [animal, in vitro — Russian studies]. Improves cognitive function in aged animals — enhanced spatial memory, reduced anxiety-like behavior [animal — Russian studies]. CEREBROVASCULAR: Used in Russian clinical practice for post-stroke cognitive rehabilitation — reported improvement in memory, attention, and executive function [Russian clinical studies, practitioner protocols]. Reduces oxidative stress in brain tissue — upregulates superoxide dismutase and glutathione peroxidase [animal]. ANTI-AGING: Part of Khavinson's broader bioregulation theory — that tissue-specific peptides decline with aging, and their supplementation restores youthful gene expression patterns [theoretical framework, animal]. Long-term (15-year) follow-up data from the Khavinson bioregulator studies in elderly populations claim reduced mortality and improved cognitive function [Russian clinical studies — Khavinson et al., 2003]. IMMUNE/SYSTEMIC: Some evidence of immunomodulatory effects — thymus peptide interactions in the Khavinson paradigm consider all bioregulators to have some cross-system effects [Russian clinical studies].
Practitioner Guide
ADMINISTRATION: Oral capsules (most common in Russian clinical use) or sublingual. Khavinson bioregulator protocols typically use Cortagen at 1-2 capsules (10-20mg) daily, taken in the morning on an empty stomach. Standard Khavinson protocol: 10-day course, 2 capsules/day, repeated every 3-6 months. Some practitioners use 20-day courses for more severe cognitive impairment. INJECTION: Injectable Cortexin (a related but different product — cortex-derived peptide complex, not identical to Cortagen tetrapeptide) is used in Russian clinical practice at 10mg IM daily for 10-20 days. Do not confuse Cortagen (synthetic tetrapeptide AEDP) with Cortexin (extracted peptide complex). STACKING (KHAVINSON PROTOCOL): Commonly combined with other bioregulators: Cerluten (brain peptide bioregulator — often alternated with Cortagen), Pinealon (pineal gland bioregulator — Glu-Asp-Arg, for sleep/circadian rhythm), Endoluten (pineal extract — for melatonin support), and Visoluten (retinal bioregulator — if visual complaints). A typical comprehensive brain protocol: Cortagen 10 days → Pinealon 10 days → Cerluten 10 days, then 3-month break. CYCLING: Essential in Khavinson paradigm — bioregulators are given in short courses to "reset" gene expression, not taken continuously. 10-day course every 3-6 months is standard. Continuous use is not recommended per Khavinson protocol. SUPPLEMENT SYNERGIES: Combine with omega-3 fatty acids (EPA/DHA 2-3g/day), phosphatidylserine (100-300mg/day), lion's mane mushroom (500-1000mg/day), and B-complex vitamins for comprehensive neurocognitive support. SOURCING: Available from Russian pharmacy sources and international peptide bioregulator retailers (Peptide Bioregulator brand). Quality and authenticity vary — source from established Khavinson-affiliated distributors when possible. STORAGE: Room temperature, dry, protected from light. Stable in capsule form. HONEST ASSESSMENT: The Khavinson bioregulator paradigm is intriguing but the evidence base is almost entirely from one research group in Russia, published primarily in Russian-language journals with limited peer review by Western standards. The mechanistic theory (short peptides regulating gene expression via direct DNA binding) is plausible but not rigorously validated by independent groups. Approach with appropriate skepticism while acknowledging that the clinical observations (particularly the long-term follow-up studies) are interesting.
Research Summary
TIER 1: No Western RCTs. No FDA/EMA regulatory submissions. Russian clinical studies (Khavinson et al.) claim efficacy but do not meet Western RCT standards — often unblinded, small sample sizes, published in Russian-language journals. The 15-year follow-up study of bioregulator supplementation in elderly showed reduced mortality (Khavinson & Morozov, 2003), but methodology has been questioned. TIER 2: Reviews of the Khavinson bioregulator paradigm (Khavinson et al., 2014 — English-language summary in Advances in Gerontology). In vitro studies showing short peptide-DNA interactions and gene expression modulation (Khavinson lab — multiple publications). Animal studies on neuroprotection and cognition (Russian journals). Theoretical reviews of peptide bioregulation as an anti-aging strategy. TIER 3: Russian clinical practitioner case series for post-stroke rehabilitation, age-related cognitive decline, and traumatic brain injury. Practitioner protocols from Russian anti-aging clinics. International biohacking community reports (limited). Eastern European and CIS country clinical experience. KEY FINDINGS: Cortagen sits within the broader Khavinson bioregulator framework — a genuinely original scientific paradigm from Russian gerontology that proposes tissue-specific short peptides regulate gene expression and can restore youthful function. The paradigm has internal consistency and decades of (Russian) clinical use. However, it has not been independently validated by Western research groups, and the publication record does not meet contemporary evidence standards. The concept is scientifically plausible (short peptides can interact with DNA) but the therapeutic claims far outpace the rigorous evidence. GAPS: No independent replication of key findings. No Western clinical trials. Mechanism of action not validated by independent groups. Pharmacokinetics of oral tetrapeptide absorption questionable (how does a 4-amino acid peptide survive digestion and reach the brain?). ACTIVE TRIALS: None on ClinicalTrials.gov. Ongoing research at the St. Petersburg Institute of Bioregulation and Gerontology.